To the Editor We read with interest an article entitled "Encephalopathy Induced by High Plasma and Cerebrospinal Fluid Ceftriaxone Concentration in a Hemodialysis Patient" by Suzuki et al. in the Internal Medicine Advanced publication (1). The authors carefully described the clinical course of a patient who suffered from encephalopathy, possibly caused by ceftriaxone. The authors carefully deduced the causes of encephalopathy, most of which were highly inductive.
A previous pharmacokinetic study revealed lower serum concentrations of ceftriaxone among hemodialysis patients (2) in comparison to the concentration recorded in this patient (>100 μg/mL) (1) . Additionally, the cerebrospinal concentration (10.2 μg/mL) of ceftriaxone in this encephalopathic patient was higher in comparison to meningitis patients (median 3.52 μg/mL), whose blood-brain barrier might be more permeable, allowing medicines to penetrate more easily from blood into the cerebrospinal fluid (3). Thus, high serum and cerebrospinal fluid concentrations might ex-plain ceftriaxone's pathogenicity.
However, these facts cannot clarify the definite cause of encephalopathy, because her symptoms and her serum concentration did not show a directly linear relationship (1) . That is, she had no consciousness disturbance, despite the high concentration of ceftriaxone on day 9 after administration of this third-generation cephaorosporin. We would like to ask the authors why she did not show any neurological symptoms when the concentration of the drug was higher.
